中文名称: | Norverapamil | ||||
---|---|---|---|---|---|
英文名称: | Norverapamil | ||||
别名: | Norverapamil (±)-Norverapamil;D591 | ||||
CAS No: | 67018-85-3 | 分子式: | C26H36N2O4 | 分子量: | 440.58 |
CAS No: | 67018-85-3 | ||||
分子式: | C26H36N2O4 | ||||
分子量: | 440.58 |
基本信息
产品编号: |
N11022 |
||||
产品名称: |
Norverapamil |
||||
CAS: |
67018-85-3 |
储存条件 |
粉末 |
-20℃ |
四年 |
分子式: |
溶于液体 |
-80℃ |
一年 |
||
分子量: |
440.58 |
|
|
||
化学名: |
Benzeneacetonitrile,a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-3,4-dimethoxy-a-(1-methylethyl)- |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
生物活性
产品描述 |
Verapamil的N-去甲基代谢物,是一种钙通道(L-typecalciumchannel)阻滞剂和P-糖蛋白(P-gp)功能抑制剂。 |
|
靶点 |
Calcium channel blocker P-glycoprotein (P-gp) inhibitor |
|
体外研究 |
Norverapamil ((±)-Norverapamil) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M.tuberculosis in the absence of other drugs.norverapamil,also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil.Verapamil and its major metabolite Norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic. |
|
体内研究 |
Norverapamil (9mg/kg;p.o.),a major metabolite of verapamil,has terminal half-life,AUC and Cmax values of 9.4 hours,260ng▪h/ml,and 41.6ng/mL,respectively. |
|
Animal Model: |
Male Sprague-Dawley rats |
|
Dosage: |
9mg/kg (Pharmacokinetic Study) |
|
Administration: |
Oral administration |
|
Result: |
t1/2=9.4 hours;AUC=260ng▪h/mL;Cmax=41.6ng/mL. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )